Inhibition of tumor angiogenesis mediated by cartilage

doi:10.1084/jem.141.2.427

This Article

	Full Text (PDF, 1140K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Brem, H
	Articles by Folkman, J
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Brem, H
	Articles by Folkman, J

Social Bookmarking

	What's this?

ARTICLES

Inhibition of tumor angiogenesis mediated by cartilage

H Brem and J Folkman

Capillary proliferation induced by tumor is shown to be inhibited by neonatal scapular cartilage. Using the rabbit cornea as an assay, the cartilage implant decreased the rate of capillary growth, induced by tumor, by an average of 75%. Vascularization was prevented completely in 28% of tumors. The inhibitory effect of small cartilage implants operates over distances of up to 2.0 mm and displays a gradient from the cartilage source. The experiments suggest that the cartilage inhibitor does not antagonize tumor angiogenesis factor, but appears to inhibit capillary proliferation directly. The inhibitory material does not elicit an inflammatory response in either the rabbit cornea or in the chick chorioallantoic membrane. Thus with further purification, it may prove useful as a means of maintining tumor dormancy by "antiangiogenesis."
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Holaday, J. W., Berkowitz, B. A. (2009). Antiangiogenic Drugs: Insights into Drug Development from Endostatin, Avastin and Thalidomide. Mol. Interv. 9: 157-166 [Full Text]
Kozyreva, O. N., Mezentsev, D. A., King, D. R., Gomez-Fernandez, C. R., Ardalan, B., Livingstone, A. S. (2007). Asymptomatic Muscle Metastases From Esophageal Adenocarcinoma. JCO 25: 3780-3783 [Full Text]
Chen, C.-H., Walterscheid, J. P. (2006). Plaque Angiogenesis Versus Compensatory Arteriogenesis in Atherosclerosis. Circ. Res. 99: 787-789 [Full Text]
Potter, B. K., Freedman, B. A., Lehman, R. A. Jr., Shawen, S. B., Kuklo, T. R., Murphey, M. D. (2005). Solitary Epiphyseal Enchondromas. JBJS 87: 1551-1560 [Abstract] [Full Text]
Rini, B. I., Small, E. J. (2005). Biology and Clinical Development of Vascular Endothelial Growth Factor-Targeted Therapy in Renal Cell Carcinoma. JCO 23: 1028-1043 [Abstract] [Full Text]
Vickers, A. (2004). Alternative Cancer Cures: "Unproven" or "Disproven"?. CA Cancer J Clin 54: 110-118 [Abstract] [Full Text]
Koch, A E (2003). Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 62: ii60-67 [Full Text]
Weiger, W. A., Smith, M., Boon, H., Richardson, M. A., Kaptchuk, T. J., Eisenberg, D. M. (2002). Advising Patients Who Seek Complementary and Alternative Medical Therapies for Cancer. ANN INTERN MED 137: 889-903 [Abstract] [Full Text]
Boivin, D., Gendron, S., Beaulieu, E., Gingras, D., Beliveau, R. (2002). The Antiangiogenic Agent Neovastat (Ae-941) Induces Endothelial Cell Apoptosis. Molecular Cancer Therapeutics 1: 795-802 [Abstract] [Full Text]
Beliveau, R., Gingras, D., Kruger, E. A., Lamy, S., Sirois, P., Simard, B., Sirois, M. G., Tranqui, L., Baffert, F., Beaulieu, E., Dimitriadou, V., Pepin, M.-C., Courjal, F., Ricard, I., Poyet, P., Falardeau, P., Figg, W. D., Dupont, E. (2002). The Antiangiogenic Agent Neovastat (Ae-941) Inhibits Vascular Endothelial Growth Factor-mediated Biological Effects. Clin. Cancer Res. 8: 1242-1250 [Abstract] [Full Text]
Hillman, J. D., Peng, A. T., Gilliam, A. C., Remick, S. C. (2001). Treatment of Kaposi Sarcoma With Oral Administration of Shark Cartilage in a Human Herpesvirus 8-Seropositive, Human Immunodeficiency Virus-Seronegative Homosexual Man. Arch Dermatol 137: 1149-1152 [Full Text]
Wong, B. J. F., Karamzadeh, A. M., Hammer-Wilson, M. J., Liaw, L.-H. L., Nelson, J. S., Milner, T. E. (2001). Angioresistance of Thermally Modified Cartilage Grafts in the Chick Chorioallantoic Membrane Model. Arch Facial Plast Surg 3: 24-27 [Abstract] [Full Text]
Koch, A. E. (2000). The role of angiogenesis in rheumatoid arthritis: recent developments. Ann Rheum Dis 59: i65-71 [Full Text]
Moses, M. A., Wiederschain, D., Wu, I., Fernandez, C. A., Ghazizadeh, V., Lane, W. S., Flynn, E., Sytkowski, A., Tao, T., Langer, R. (1999). Troponin I is present in human cartilage and inhibits angiogenesis. Proc. Natl. Acad. Sci. USA 96: 2645-2650 [Abstract] [Full Text]
Britt, J. C., Park, S. S. (1998). Autogenous Tissue-Engineered Cartilage: Evaluation as an Implant Material. Arch Otolaryngol Head Neck Surg 124: 671-677 [Abstract] [Full Text]
Naumov, Y. N., Hogan, K. T., Naumova, E. N., Pagel, J. T., Gorski, J. (1998). A Class I MHC-Restricted Recall Response to a Viral Peptide Is Highly Polyclonal Despite Stringent CDR3 Selection: Implications for Establishing Memory T Cell Repertoires in ""Real-World"" Conditions. J. Immunol. 160: 2842-2852 [Abstract] [Full Text]
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., Chan, S.-Y., Roczniak, S., Shanafelt, A. B. (1995). The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis. J. Biol. Chem. 270: 27348-27357 [Abstract] [Full Text]
Moses, M., Sudhalter, J, Langer, R (1990). Identification of an inhibitor of neovascularization from cartilage. Science 248: 1408-1410 [Abstract]
Glaser, B. M., Campochiaro, P. A., Davis, J. L. Jr, Sato, M. (1985). Retinal Pigment Epithelial Cells Release an Inhibitor of Neovascularization. Arch Ophthalmol 103: 1870-1875 [Abstract]
Langer, R, Brem, H, Falterman, K, Klein, M, Folkman, J (1976). Isolations of a cartilage factor that inhibits tumor neovascularization. Science 193: 70-72 [Abstract]